UNSPSC 51111751: Ortetamine

This classification denotes an anorexiant with the molecular formula C10H15N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VF4N11KKKR, chemically known as 1,1-dimethyl-2-phenylethylamine but generally known as ortetamine, which bears US NIH Compound Identifier 4771. European Medicines Agency schedules Ortetamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09472MIG. The term ORTETAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5).

UNSPSC 51111751 Ortetamine, a Commodity code, nominally covers a specific pharmaceutical active ingredient, but the recent state and local opportunities tagged under this code show a mismatch between the code's name and the work actually being solicited. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC for supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—neither of which is ortetamine. Similarly, Seminole County, Florida issued a competitive bid for Naloxone and Safe Drug Deactivation Systems. The code shows little relevant recent activity aligned with its nominal pharmaceutical scope, and the two posted opportunities appear to be misclassified under this code or represent state and local agencies using the taxonomy inconsistently for pharmaceutical procurement broadly.

No open solicitations currently active under UNSPSC 51111751 warrant pursuit. The Illinois award (Bid Number 26-482DPH-PREPD-B-53392, completed August 28, 2026) was a closed IFB with a total value of $2,999,999.11 over 36 months including renewals, already awarded to Chartwell Rx LLC; the Seminole County opportunity listed a due date of July 26, 2023—a date in the past relative to today's date (October 20, 2026). Business developers should verify whether state and local procurement offices are applying this code consistently to ortetamine-specific opportunities or whether the taxonomy misclassification is widespread across these jurisdictions before allocating pursuit resources to this Commodity code.